Rep. Maria Elvira Salazar discloses trade(s) in CB, IBM, MRK, MRNA, QCOM
Maria Elvira Salazar (FL27) disclosed 12 transactions, traded Aug 7 – Aug 24: 6 purchases and 6 sales.
| Traded | Ticker | Company | Action | Amount | Owner |
|---|---|---|---|---|---|
| Aug 24 | IBM | UBS Brokerage Account International Business Machines Corporation | Sell (partial) | $1,001 - $15,000 | Self |
| Aug 24 | IBM | UBS Brokerage Account International Business Machines Corporation | Sell (partial) | $1,001 - $15,000 | Self |
| Aug 19 | CB | UBS IRA Account Chubb Limited | Sell | $15,001 - $50,000 | Self |
| Aug 19 | MRK | UBS IRA Account Merck & Company, Inc. | Buy | $15,001 - $50,000 | Self |
| Aug 19 | MRK | UBS IRA Account Merck & Company, Inc. | Buy | $15,001 - $50,000 | Self |
| Aug 19 | MRNA | UBS Brokerage Account Moderna, Inc. | Sell (partial) | $1,001 - $15,000 | Self |
| Aug 19 | MRNA | UBS Brokerage Account Moderna, Inc. | Buy | $1,001 - $15,000 | Self |
| Aug 19 | QCOM | UBS IRA Account QUALCOMM Incorporated | Sell | $1,001 - $15,000 | Self |
| Aug 12 | QCOM | UBS IRA Account QUALCOMM Incorporated | Sell | $1,001 - $15,000 | Self |
| Aug 12 | SPCX | UBS Brokerage Account Space Exploration Technologies Corp. | Buy | $1,001 - $15,000 | Self |
| Aug 12 | SPCX | UBS IRA Account Space Exploration Technologies Corp. | Buy | $1,001 - $15,000 | Self |
| Aug 7 | BRK.B | Berkshire Hathaway Inc. New | Buy | $1,001 - $15,000 | Self |
ORIGINAL FILING ↗ALL FILINGS BY MARIA ELVIRA SALAZAR →CONGRESS TRADES DASHBOARD →
Amounts are the ranges members report. Rows are read automatically from the filing; a trade split across a page break can be missed, so the original filing is the full record.
What This Means
A U.S. representative filed required disclosures of stock transactions across five companies spanning financial services, technology, pharmaceuticals, and semiconductors. Congressional stock trading disclosures are public records that can signal insider positioning or serve as a transparency mechanism under the STOCK Act framework. Such filings are tracked by markets observers and governance-focused investors as part of broader monitoring of legislative activity and potential conflicts of interest.
Sources — 1 tier
Every claim below links directly to the original reporting it was drawn from. Penblock synthesizes and cross-references these sources — it doesn't originate the reporting.
- Maria Elvira SalazarOct 3, 2026View the original filing at the House Clerk ↗
How This Could Play Out — recorded when first flagged, not updated
Resolve
UNLIKELYIf these trades trigger formal ethics review or legislative action on insider trading rules, resulting in stricter enforcement or new restrictions on congressional trading, it could modestly increase compliance costs for financial institutions managing political accounts but would unlikely move broad equity indices.
Left Unattended
LIKELYThese disclosures remain routine filings without generating sustained media attention or regulatory scrutiny, in which case they would have no material market effect beyond the ordinary noise of individual portfolio rebalancing.
Escalate
POSSIBLEIf the timing or pattern of these trades—particularly in healthcare (MRK, MRNA) or semiconductors (QCOM, IBM)—becomes the subject of investigation for potential coordination with legislative action or committee work, it could create reputational pressure on the affected companies and heighten scrutiny of congressional trading practices more broadly.
SPONSORED
Confidence History
- HIGH CONFIDENCEOct 3, 2026 at 12:02 PM
Legally mandated financial disclosure filing -- primary source, not a report about the event